Developing Asthma Interventions Using Community Based Research
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to identify community resources and challenges in improving the health of community members with asthma.
The primary goal of this project is to use Community-Based Participatory Research methodology to develop interventions aimed at improving asthma management in high-risk African American asthmatics. This "ground-up" longterm approach has never been tested before in asthmatics. The primary goal of this study will be accomplished with four specific aims:
Aim 1. Conduct focus groups to identify barriers to asthma management in the target population.
Aim 2. Use a community advisory board (CAB) consisting of participants selected from the various focus groups to gather information about solutions for the above barriers.
Aim 3. Use the information from the CAB to develop an intervention to improve asthma self management behaviors in the target population.
Aim 4. Refine the developed intervention based on feedback from focus groups conducted in Aim 1.
| Condition |
|---|
|
Asthma |
| Study Type: | Observational |
| Study Design: | Observational Model: Ecologic or Community Time Perspective: Cross-Sectional |
| Official Title: | Feasibility of Developing an Effective Asthma Intervention Using CBPR Methods |
- Use information from Community Based Participatory Research to develop an intervention to improve asthma self management behaviors. [ Time Frame: 2 years ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 62 |
| Study Start Date: | July 2008 |
| Study Completion Date: | July 2009 |
| Primary Completion Date: | July 2009 (Final data collection date for primary outcome measure) |
Volunteer will be asked to respond to several questions that address their perceptions about asthma. Volunteers will also be asked to discuss their beliefs about asthma. Everyone in the group will be given an opportunity to answer questions. Volunteers can decide that they no longer want to participate in the group discussion at any time.
The discussion will last from 1.5 - 2 hours. The focus group discussion will have a maximum of 10 people.
We will be audio and video taping the discussion so that we do not miss any information that volunteers share with us. The audio and video tapes will not be shared with anyone outside our staff.
Volunteer participation in this study is voluntary and there will be no negative consequences if volunteers decide not to participate. Volunteers are also free to withdraw from this study at any time. Withdrawal or refusal to participate will not affect health care services or other rights.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
African-American, 18 years and older
Inclusion Criteria:
- Self-identified African-American, 18 yrs. or older, resident of Davidson County, Tennessee at least 1 year.
Exclusion Criteria:
- Under 18 yrs. of age
- Non-African American
- Non-English speaking
- Do not reside in Davidson County, Tennessee
Contacts and Locations| United States, Tennessee | |
| Meharry Medical College | |
| Nashville, Tennessee, United States, 37217 | |
| Principal Investigator: | David S Trochtenberg, MD | Meharry Medical College |
More Information
No publications provided
| Responsible Party: | David Scott Trochtenberg, M.D., Meharry Medical College |
| ClinicalTrials.gov Identifier: | NCT00728169 History of Changes |
| Other Study ID Numbers: | 020715JEM13314, P20RR011792 |
| Study First Received: | July 31, 2008 |
| Last Updated: | September 17, 2009 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Meharry Medical College:
|
Asthma Focus Group Community Based Participatory Research |
Additional relevant MeSH terms:
|
Asthma Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Lung Diseases |
Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases |
ClinicalTrials.gov processed this record on June 17, 2013